No Significant Changes to Residual Viremia After Switch to Dolutegravir and Lamivudine in a Randomized Trial
Open Access
- 11 February 2019
- journal article
- research article
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 6 (3) , ofz056
Abstract
In the ASPIRE trial, antiretroviral therapy (ART) switch to dolutegravir plus lamivudine (DTG+3TC) was comparable to 3-drug ART in maintaining viral suppression by standard viral load assays. We used an ultrasensitive assay to assess whether this switch led to increased residual viremia. At entry, levels of residual viremia did not differ significantly between arms (DTG+3TC vs 3-drug ART: mean, 5.0 vs 4.2 HIV-1 RNA copies/mL; P = .64). After randomization, no significant between-group differences were found at either week 24 or 48. These results show no evidence for increased viral replication on DTG+3TC and support its further investigation as a dual ART strategy.Keywords
Funding Information
- Emory CFAR (P30AI050409)
This publication has 26 references indexed in Scilit:
- The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United StatesClinical Infectious Diseases, 2015
- The size of the expressed HIV reservoir predicts timing of viral rebound after treatment interruptionAIDS, 2015
- Switch to maraviroc/raltegravir dual therapy leads to an unfavorable immune profile with low-level HIV viremiaAIDS, 2015
- Differential Levels of Soluble Inflammatory Markers by Human Immunodeficiency Virus Controller Status and DemographicsOpen Forum Infectious Diseases, 2015
- Relationship of HIV reservoir characteristics with immune status and viral rebound kinetics in an HIV therapeutic vaccine studyAIDS, 2014
- Improved Single-Copy Assays for Quantification of Persistent HIV-1 Viremia in Patients on Suppressive Antiretroviral TherapyJournal of Clinical Microbiology, 2014
- Antiretroviral-Free HIV-1 Remission and Viral Rebound After Allogeneic Stem Cell TransplantationAnnals of Internal Medicine, 2014
- Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremiaAIDS, 2014
- Long-Term Reduction in Peripheral Blood HIV Type 1 Reservoirs Following Reduced-Intensity Conditioning Allogeneic Stem Cell TransplantationThe Journal of Infectious Diseases, 2013
- New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in PlasmaJournal of Clinical Microbiology, 2003